{
    "nctId": "NCT06518200",
    "briefTitle": "Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support",
    "officialTitle": "ATOPE-PRO: Effects on the Prevention of Breast Cancer Therapy-related Cardiovascular Toxicity of a Daily-adapted and Individualized Program With Support From a Mobile Application",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 102,
    "primaryOutcomeMeasure": "Cardiotoxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Recently diagnosed with stage I-III breast cancer\n* Treatments predisposing to cardiotoxicity (anthracyclines, targeted therapies, radiotherapy)\n* Signed informed consent form\n* Medical authorisation to participate\n* Smartphone user level\n\nExclusion Criteria:\n\n* Patient underwent previous cancer treatments.\n* Patients were previously diagnosed with cancer\n* Pregnant patients. Patients performing other type of therapeutic exercise at diagnosis time with an intake \\>or = to 150 moderate-intensity or 75 min of vigorous-intensity a day\n* Therapeutic exercise practice not recommended because psychiatric or cognitive disorders or cute or chronic condition that prevents exercise (advanced lung disease, oxygen requirement, stenosis \\>70%, metastasis etc.).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}